NewAmsterdam Pharma Co N.V. (NAMS) stock
NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
$19.39−0.07 (-0.36%)
Close on Nov 17, 2026Market cap $2.32BP/E –Yield –
NewAmsterdam Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NewAmsterdam Pharma's enterprise value was $1.80B on Nov 11, 2026, against $3.97B a year earlier. Over the last 5 years it ranged from $48.75M to $3.97B, with a median of $1.20B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.80B | -44.8% |
| 2025 | Dec 31, 2025 | $3.27B | +67.9% |
| 2024 | Dec 31, 2024 | $1.95B | +339.0% |
| 2023 | Dec 29, 2023 | $443.29M | +259.1% |
| 2022 | Dec 30, 2022 | $123.45M | +153.2% |
| 2021 | Dec 31, 2021 | $48.75M | – |
See a number that looks wrong?